[fcb5af]: / literature / by_gene / RARA.tsv

Download this file

# pmid doi year title Hugo_Symbol
1 31555723 10.1177/2374289519875647 2022 Educational Case: Acute Promyelocytic Leukemia With <i>PML-RARA</i>. RARA
2 34543560 10.24875/RMIMSS.M20000079 2022 Panhypopituitarism and cranial mononeuropathy, manifestation of NK/T lymphoma that imitates meningeal tuberculosis. RARA
3 34543562 10.24875/RMIMSS.M20000081 2022 Two lymphomas in the same patient: A case report. RARA
4 34668451 10.1080/10428194.2021.1992757 2022 Value of measurable residual disease monitoring in patients with acute promyelocytic leukemia in the era of frontline 'chemotherapy-free' therapy. RARA
5 35198449 10.3389/fonc.2022.828852 2022 Clinical Response to Venetoclax and Decitabine in Acute Promyelocytic Leukemia With a Novel RARA-THRAP3 Fusion: A Case Report. RARA
6 35459386 2022 Preleukemic fusion genes typical for acute myeloid leukemia. RARA
7 31809670 10.1080/10428194.2019.1699081 2021 Characterization of a cryptic <i>PML-RARA</i> fusion by mate-pair sequencing in a case of acute promyelocytic leukemia with a normal karyotype and negative <i>RARA</i> FISH studies. RARA
8 32033928 10.1016/j.clml.2019.08.006 2021 Prognostic Significance of bcr-1 and bcr-3 Isoforms of PML-RARA and FLT3-ITD in Patients With Acute Promyelocytic Leukemia. RARA
9 32322022 10.1038/s41379-020-0533-0 2021 Morphologic and genetic heterogeneity in breast fibroepithelial lesions-a comprehensive mapping study. RARA
10 32354871 10.3324/haematol.2019.244715 2021 Novel reciprocal fusion genes involving <i>HNRNPC</i> and <i>RARG</i> in acute promyelocytic leukemia lacking <i>RARA</i> rearrangement. RARA
11 32657180 10.1080/10428194.2020.1791853 2021 Acute promyelocytic leukemia (APL) with an <i>IRF2BP2-RARA</i> fusion transcript: an aggressive APL variant. RARA
12 32907914 10.1136/jclinpath-2020-207013 2021 Gene of the month: <i>GTF2I</i>. RARA
13 32909480 10.1080/10428194.2020.1808202 2021 Cytogenetically cryptic and fish negative PML/RARA rearrangement in acute promyelocytic leukemia detected by RT-PCR. RARA
14 33131362 10.1142/S0219720020500298 2021 Comparison of gene regulatory networks to identify pathogenic genes for lymphoma. RARA
15 33298649 10.11406/rinketsu.61.1577 2021 [Therapy-related acute promyelocytic leukemia with complex karyotype accompanied by cryptic PML/RARA on chromosome 15 by metaphase FISH]. RARA
16 33973643 10.5146/tjpath.2021.01524 2021 Clinicopathological Evaluation of Acute Leukemias in a Tertiary Care Hospital: A Cross-Sectional Study. RARA
17 34744341 10.1007/s12288-021-01404-1 2021 An Outcome Analysis of Childhood Acute Promyelocytic Leukemia Treated with Atra and Arsenic Trioxide, and Limited Dose Anthracycline. RARA
18 30328750 10.1080/10428194.2018.1520991 2020 Co-expression of AML1-ETO and PML-RARa following treatment of de novo acute myeloid leukemia with AML1-ETO. RARA
19 30407095 10.1080/10428194.2018.1504941 2020 Long-term effect of all-trans retinoic acid and arsenic trioxide sequential maintenance in patients with acute promyelocytic leukemia. RARA
20 30806106 10.1080/10428194.2019.1581927 2020 Myeloid neoplasm with eosinophilia and <i>PCM1-JAK2</i> associated with acute promyelocytic leukemia with <i>PML-RARA</i>. RARA
21 31411343 10.1002/path.5333 2020 Genomic characterisation of breast fibroepithelial lesions in an international cohort. RARA
22 27468869 10.4149/neo_2016_502 2019 Incidence of preleukemic fusion genes in healthy subjects. RARA
23 28760054 10.1080/10428194.2017.1357176 2019 Successful treatment of a patient with acute promyelocytic leukemia with a STAT5B/RARA fusion gene using decitabine. RARA
24 28838264 10.1080/10428194.2017.1369067 2019 Comparative genomic analysis of PML and RARA breakpoints in paired diagnosis/relapse samples of patients with acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy. RARA
25 29350080 10.1080/10428194.2017.1421761 2019 IRF2BP2-RARA t(1;17)(q42.3;q21.2) APL blasts differentiate in response to all-trans retinoic acid. RARA
26 30701458 10.1007/s11033-019-04649-2 2019 Molecular profiling of adult acute myeloid and lymphoid leukemia in a major referral center in Lebanon: a 10-year experience report and review of the literature. RARA
27 30809981 10.3343/alm.2019.39.4.358 2019 The Incidence and Immunophenotypic and Genetic Features of JL1 Expressing Cells and the Therapeutic Potential of an Anti-JL1 Antibody in <i>De Novo</i> Pediatric Acute Leukemias. RARA
28 27899039 10.1080/10428194.2016.1262033 2018 Sensitive monitoring of acute promyelocytic leukemia by PML-RARA DNA Q-PCR. RARA
29 27911132 10.1080/10428194.2016.1262952 2018 A new acute myeloid leukemia case with STAT5B-RARA gene fusion due to 17q21.2 interstitial deletion. RARA
30 28370539 10.1111/exd.13348 2018 RARα/RXR synergism potentiates retinoid responsiveness in cutaneous T-cell lymphoma cell lines. RARA
31 28412739 10.18632/oncotarget.15441 2018 Retinoic acid receptor alpha drives cell cycle progression and is associated with increased sensitivity to retinoids in T-cell lymphoma. RARA
32 28540746 10.1080/10428194.2017.1324156 2018 KDM3B shows tumor-suppressive activity and transcriptionally regulates HOXA1 through retinoic acid response elements in acute myeloid leukemia. RARA
33 29105243 10.1111/ped.13451 2018 Multiplex fusion gene testing in pediatric acute myeloid leukemia. RARA
34 26685769 10.1016/S2352-3026(15)00115-5 2017 Use of arsenic trioxide in remission induction and consolidation therapy for acute promyelocytic leukaemia in the Australasian Leukaemia and Lymphoma Group (ALLG) APML4 study: a non-randomised phase 2 trial. RARA
35 26754533 10.3109/10428194.2015.1124992 2017 The leukemic oncoprotein NPM1-RARA inhibits TP53 activity. RARA
36 26871368 10.1080/10245332.2015.1106816 2017 Fusion genes in malignant neoplastic disorders of haematopoietic system. RARA
37 27608133 10.1080/10799893.2016.1225309 2017 A systems biology approach for elucidating the interaction of curcumin with Fanconi anemia FANC G protein and the key disease targets of leukemia. RARA
38 27632978 10.1186/s13000-016-0541-z 2017 Multiplexed automated digital quantification of fusion transcripts: comparative study with fluorescent in-situ hybridization (FISH) technique in acute leukemia patients. RARA
39 28238096 10.1007/s00277-017-2948-3 2017 Clinical impact of galectin-3 in newly diagnosed t (15;17)(q22;q21)/PML-RARa acute promyelocytic leukemia treated with all-trans retinoic acid and arsenic trioxide-based regimens. RARA
40 28694326 10.1182/blood-2017-02-768234 2017 Genomic analysis of 220 CTCLs identifies a novel recurrent gain-of-function alteration in RLTPR (p.Q575E). RARA
41 28885361 10.1097/MD.0000000000008001 2017 Angioimmunoblastic T-cell lymphoma and hypereosinophilic syndrome with FIP1L1/PDGFRA fusion gene effectively treated with imatinib: A case report. RARA
42 24160850 10.3109/10428194.2013.842985 2016 Arsenic trioxide in front-line therapy of acute promyelocytic leukemia (C9710): prognostic significance of FLT3 mutations and complex karyotype. RARA
43 25629986 10.3109/10428194.2015.1007454 2016 Novel STAT5B-RARA fusion transcript in acute promyelocytic leukemia: identification and treatment response. RARA
44 25791120 10.3109/10428194.2015.1023799 2016 NPM-RAR binding to TRADD selectively inhibits caspase activation, while allowing activation of NFκB and JNK. RARA
45 25908172 10.1007/s13277-015-3410-6 2016 Bioinformatics analyses of significant prognostic risk markers for thyroid papillary carcinoma. RARA
46 26012882 10.1002/cmdc.201500150 2016 Modulation of Retinoic Acid Receptor Subtypes by 5- and 8-Substituted (Naphthalen-2-yl)-based Arotinoids. RARA
47 23927396 10.3109/10428194.2013.830303 2015 NPM-RAR, not the RAR-NPM reciprocal t(5;17)(q35;q21) acute promyelocytic leukemia fusion protein, inhibits myeloid differentiation. RARA
48 25231683 10.3892/mmr.2014.2568 2015 All-trans retinoic acid suppresses apoptosis in PC12 cells injured by oxygen and glucose deprivation via the retinoic acid receptor α signaling pathway. RARA
49 25088254 10.1016/j.yexcr.2014.07.024 2014 BCL-xL/MCL-1 inhibition and RARγ antagonism work cooperatively in human HL60 leukemia cells. RARA
50 23529927 10.1182/blood-2012-08-445130 2013 A critical role for the retinoic acid signaling pathway in the pathophysiology of gastrointestinal graft-versus-host disease. RARA
51 21729689 10.1016/j.clml.2011.03.036 2012 A case of acute promyelocytic leukemia without RARα rearrangement and apparently normal cytogenetics. RARA
52 22289359 10.1016/j.taap.2012.01.011 2012 Inhibitory effects of azole-type fungicides on interleukin-17 gene expression via retinoic acid receptor-related orphan receptors α and γ. RARA
53 22311672 10.1158/0008-5472.CAN-11-2505 2012 Retinoic acid/alpha-interferon combination inhibits growth and promotes apoptosis in mantle cell lymphoma through Akt-dependent modulation of critical targets. RARA
54 22450142 10.1556/OH.2012.29334 2012 [Leukemia- and lymphoma-associated flow cytometric, cytogenetic, and molecular genetic aberrations in healthy individuals]. RARA
55 21115433 10.3816/CLML.2010.s.027 2011 Utilization of molecular phenotypes to detect relapse and optimize the management of acute promyelocytic leukemia. RARA
56 21344764 2011 [Genotyping and minimal residual disease study in children with acute myeloid leukemia: preliminary results]. RARA
57 21354057 10.1016/j.jmoldx.2010.10.009 2011 Common leukemia- and lymphoma-associated genetic aberrations in healthy individuals. RARA
58 21803845 10.1182/blood-2011-04-349670 2011 PMLRARα binds to Fas and suppresses Fas-mediated apoptosis through recruiting c-FLIP in vivo. RARA
59 20211010 10.1186/1755-8794-3-6 2010 Gene expression signatures in childhood acute leukemias are largely unique and distinct from those of normal tissues and other malignancies. RARA
60 20362228 10.1016/j.cancergencyto.2010.01.005 2010 Cytogenetic studies in acute leukemia patients relapsing after allogeneic stem cell transplantation. RARA
61 20425800 10.1002/ajh.21683 2010 Acute leukemia association with psoriasis: a report on 100 patients from a single center in China. RARA
62 20507312 10.1111/j.1365-2141.2010.08209.x 2010 All trans retinoic acid nanodisks enhance retinoic acid receptor mediated apoptosis and cell cycle arrest in mantle cell lymphoma. RARA
63 20572854 10.1111/j.1600-0722.2010.00729.x 2010 MTHFR and MSX1 contribute to the risk of nonsyndromic cleft lip/palate. RARA
64 18974375 10.1182/blood-2008-02-140996 2009 Gene expression profiling of pulmonary mucosa-associated lymphoid tissue lymphoma identifies new biologic insights with potential diagnostic and therapeutic applications. RARA
65 19142993 10.1002/pbc.21915 2009 Simultaneous occurrence of MLL and RARA rearrangements in a pediatric acute lymphoblastic leukemia patient. RARA
66 19557639 10.1080/10428190902934936 2009 Function of retinoid acid receptor alpha and p21 in all-trans-retinoic acid-induced acute T-lymphoblastic leukemia apoptosis. RARA
67 17581672 10.1590/s0100-879x2007000600002 2008 Acute leukemia in early childhood. RARA
68 18324966 10.1111/j.1365-2141.2008.07023.x 2008 Therapy-associated genetic aberrations in patients treated for non-Hodgkin lymphoma. RARA
69 18665825 10.1111/j.1751-553X.2007.00954.x 2008 Simple multiplex RT-PCR for identifying common fusion transcripts in childhood acute leukemia. RARA
70 16638186 2007 [Detection of fusion genes associated with specific translocations in acute leukemia patients with normal karyotypes by using multiplex RT-PCR]. RARA
71 16840198 10.1080/10428190500463932 2007 Single-agent liposomal all-trans retinoic acid can cure some patients with untreated acute promyelocytic leukemia: an update of The University of Texas M. D. Anderson Cancer Center Series. RARA
72 17272867 10.1007/BF03194663 2007 Few associations of candidate genes with nonsyndromic orofacial clefts in the population of Lithuania. RARA
73 17375301 10.1007/s00277-007-0253-2 2007 Diagnostic pathways in acute leukemias: a proposal for a multimodal approach. RARA
74 17454588 10.1080/10428190601136163 2007 Acute promyelocytic leukemia: a novel PML/RARalpha fusion that generates a frameshift in the RARalpha transcript and ATRA resistance. RARA
75 16239915 10.1038/sj.leu.2403937 2006 Aberrant promoter methylation of the retinoic acid receptor alpha gene in acute promyelocytic leukemia. RARA
76 16261608 10.1002/pbc.20654 2006 Molecular cytogenetic findings of acute leukemia included in the Brazilian Collaborative Study Group of Infant acute leukemia. RARA
77 16273555 10.1002/mc.20144 2006 Induction of murine leukemia and lymphoma by dominant negative retinoic acid receptor alpha. RARA
78 16311697 10.4067/s0034-98872005000900008 2006 [Possible association due to linkage disequilibrium of TGFA, RARA and BCL3 with nonsyndromic cleft lip with or without cleft palate in the Chilean population]. RARA
79 16563162 10.1186/1476-4598-5-12 2006 Dominant negative retinoic acid receptor initiates tumor formation in mice. RARA
80 16765349 10.1016/j.febslet.2006.05.052 2006 Increased p21 expression and complex formation with cyclin E/CDK2 in retinoid-induced pre-B lymphoma cell apoptosis. RARA
81 16893685 10.1016/j.dnarep.2006.05.020 2006 Chromatin structural elements and chromosomal translocations in leukemia. RARA
82 16984370 10.1111/j.1349-7006.2006.00270.x 2006 Nucleophosmin: a versatile molecule associated with hematological malignancies. RARA
83 11424005 10.1038/sj/thj/6200098 2005 Retinoic acid dramatically enhances the arsenic trioxide-induced cell cycle arrest and apoptosis in retinoic acid receptor alpha-positive human T-cell lymphotropic virus type-I-transformed cells. RARA
84 15486192 2005 Peroxisome proliferator-activated receptor gamma and retinoid X receptor ligands are potent inducers of differentiation and apoptosis in leukemias. RARA
85 15843827 10.1038/sj.leu.2403749 2005 Gene expression profiling of leukemic cell lines reveals conserved molecular signatures among subtypes with specific genetic aberrations. RARA
86 16019491 10.1080/10428190412331272730 2005 Biphenotypic acute leukemia with t(15;17). RARA
87 16019559 10.1080/10428190500102589 2005 Upregulated hoxC4 induces CD14 expression during the differentiation of acute promyelocytic leukemia cells. RARA
88 16080957 10.1016/j.cancergencyto.2004.12.021 2005 Cytogenetic characterization of a BCR-ABL transduced mouse cell line. RARA
89 14959844 10.1080/1042819031000116670 2004 Cross-talk between retinoic acid and STAT3 signaling pathways in acute promyelocytic leukemia. RARA
90 14970276 10.1093/jnci/djh043 2004 Loss of the tumor suppressor PML in human cancers of multiple histologic origins. RARA
91 15218416 10.1097/00043426-200407000-00005 2004 Secondary acute promyelocytic leukemia following chemotherapy for non-Hodgkin's lymphoma in a child. RARA
92 15291358 10.1080/1042819031000151833 2004 Nuclear retinoid receptors are involved in N-(4-hydroxyphenyl) retinamide (Fenretinide)-induced gene expression and growth inhibition in HL-60 acute myeloid leukemia cells. RARA
93 15291362 10.1080/1042819031000163887 2004 Granulocytic differentiation of leukemic cells with t(9;11)(p22;q23) induced by all-trans-retinoic acid. RARA
94 12691149 10.1080/1042819021000040305 2003 Cytogenetics, FISH and RT-PCR analysis of acute promyelocytic leukemia: structure of the fusion point in a case lacking classic t(15;17) translocation. RARA
95 14534537 10.1038/sj.onc.1206747 2003 Leukemia-associated translocation products able to activate RAS modify PML and render cells sensitive to arsenic-induced apoptosis. RARA
96 14585279 10.1016/s1521-6616(03)00208-0 2003 Profiling aberrant DNA methylation in hematologic neoplasms: a view from the tip of the iceberg. RARA
97 11699203 10.3109/10428190109097687 2002 Acute promyelocytic leukemia with apparently normal karyotype: molecular findings and response to all-trans retinoic acid. RARA
98 11862881 2002 Candidate genes for nonsyndromic cleft lip and palate. RARA
99 12006543 2002 Induction of apoptosis by bexarotene in cutaneous T-cell lymphoma cells: relevance to mechanism of therapeutic action. RARA
100 11211936 10.1078/0171-9335-00141 2001 Retinoic acid-induced blr1 expression requires RARalpha, RXR, and MAPK activation and uses ERK2 but not JNK/SAPK to accelerate cell differentiation. RARA